Purpose To prospectively analyze, using validated outcome measures, symptom improvement in patients with mild to moderate cubital tunnel syndrome treated with rigid night splinting and activity modifications.
C UBITAL TUNNEL SYNDROME is the second most common nerve compression syndrome, and the cubital tunnel is the most common site of ulnar nerve compression. 1, 2 Research regarding the anatomy of the ulnar nerve and the causes of ulnar nerve dysfunction suggests that cubital tunnel syndrome is likely multifactorial with components of direct compression as well as traction on the nerve related to elbow flexion. 3, 4 The degree of nerve dysfunction may be classified based on the work by McGowan, 5 later modified by Dellon, 1 that categorizes nerve dysfunction as mild, moderate, or severe based on history and physical examination findings. Mild disease, Dellon 1, is limited to intermittent paresthesias and subjective weakness; moderate disease, Dellon 2, includes intermittent paresthesias and objective weakness; severe disease, Dellon 3, has persistent paresthesias and objective weakness with or without intrinsic atrophy. 1, [5] [6] [7] The initial treatment of cubital tunnel syndrome may be nonoperative, which includes activity modification, nerve gliding exercises, and splinting. 8 -10 A trial of conservative care is considered appropriate for patients with Dellon 1 symptoms. An understanding of the increased extraneural and intraneural pressure demonstrated in ulnar nerve compression has helped to better define conservative treatment options, especially splinting. It has been shown that prolonged elbow flexion, static or repetitive, induces strain on the ulnar nerve and increased extraneural and intraneural pressures within the cubital tunnel. These intra-and extraneural pressures are at their lowest mean values at an elbow position of 40°to 50°o f flexion, and pressures are significantly greater in full elbow flexion or extension. 11 The goals of splinting are to alleviate symptoms and prevent progressive nerve dysfunction.
Various forms of splinting have been used in the treatment of cubital tunnel syndrome ranging from padded sleeves to rigid thermoplastic custom-fit orthoses. Patient compliance with splinting regimens can be difficult and represents a limiting factor in the utility of this treatment. Outcomes have been examined, but splint compliance and duration of splinting remain uncertain. [12] [13] [14] In addition, the response of patients with Dellon 2 symptoms to conservative care is unclear. 9, 12, 15 Our goal in this investigation was to prospectively analyze, with validated patient-rated outcome measures, symptom improvement in patients with mild to moderate cubital tunnel syndrome treated with rigid night splinting and activity modification. We also assessed splint compliance during the 3-month trial. We hypothesized that patients treated with a 3-month course of rigid night splinting and activity modification would comply with the splinting protocol and demonstrate a clinically relevant and statistically significant improvement in validated outcome measures of both upper extremity function and general health measures.
MATERIALS AND METHODS
After institutional review board approval, patients were prospectively enrolled from our hand clinic between August 2009 and January 2011. Any adult patient diagnosed with an idiopathic cubital tunnel syndrome by typical findings on history, physical examination, and/or nerve studies who was amenable to both nonoperative and operative treatment was eligible for inclusion. We graded the severity of cubital tunnel symptoms according to Dellon's classification. The distinction between mild, Dellon 1, and moderate, Dellon 2, disease was made based on weakness in grip/pinch strength of less than 80% of the contralateral, unaffected extremity. For those patients with bilateral disease, strength classification was based on Dellon's grip/pinch strength criteria because an uninvolved contralateral extremity was not available. 12 We excluded patients with severe, Dellon 3, disease because we advised them to have surgery. Patients with cubital tunnel syndrome secondary to elbow deformity, a congenital anomaly, a prior trauma, cervical radiculopathy, or previous elbow surgery were also excluded. Workers' compensation patients were excluded owing to potential confounding as a result of secondary gain considerations. Although we did not exclude patients with a generalized neurological condition or diabetes, none of our patients had these conditions. Nineteen patients (25 extremities) were enrolled. The 8 men and 11 women had a mean age of 43 years (range, 21-72 y). There were 20 extremities with Dellon 1 disease and 5 with Dellon 2 disease. Symptoms had been present an average of 7 months (range, 1-41 mo) before presentation, and 5 patients had experienced symptoms for more than 6 months. Twenty-four of the 25 extremities were available at a minimum follow-up of 1 year with a mean follow-up of 2 years (range, 15-32 mo). One patient with Dellon 2 disease was lost to follow-up and was excluded from final analysis.
All patients were treated with a rigid nighttime orthosis holding the elbow at a position of 45°of flexion for 3 months. We allowed the orthosis (Hely & Weber, Santa Paula, CA) to be discontinued at 3 months (Fig.  1) . The selected orthosis included malleable aluminum stays that allowed the orthosis to be molded to maintain the elbow at 45°of flexion. In addition, each patient was given information regarding his or her diagnosis and various activity modifications to help reduce day-time aggravation of the ulnar nerve (Appendix A; available on the Journal's Web site at www.jhandsurg.org).
Patients were evaluated at enrollment and at 6 weeks, 3 months, 1 year, and at final follow-up as detailed later. Treatment failure was defined as progression to surgical intervention for cubital tunnel syndrome. The primary outcome measures were the Quick-DASH (Quick Disabilities of the Arm, Shoulder, and Hand questionnaire), the Short Form 12-Item questionnaire (SF-12), and self-reported splinting compliance during the first 3 months of treatment (100%, Ͼ 80%, Ͼ 50%, Ͻ 50%, 0%). Treatment outcome was assessed by resolution or improvement of symptoms and improved QuickDASH and SF-12 scores. Per our standard clinical practice, all patients were requested to attempt conservative management with night splinting for a minimum of 3 months. After that, any persistent symptoms deemed unacceptable by the patient could be treated surgically.
Subjective assessment
The QuickDASH and SF-12 questionnaires were completed at study enrollment for baseline data and at 6 weeks, 3 months, and at a minimum 1 year follow-up for final evaluation. The DASH is a 30-item questionnaire that measures function, symptoms, and quality-of-life issues related to upper extremity pathology. 16 It is scored from 0 to 100 with a higher score representing greater disability and a minimal clinically important difference of 10 points. 17 It has been validated and tested for reproducibility. 18, 19 The QuickDASH is an 11-item version of the DASH that has been shown to correlate well with the DASH score in previous studies. 17 The SF-12 is an abbreviated version of the ShortForm Health Survey 36 (SF-36). It is valid and reliable in the general population as a general health measurement scale. The SF-12 has 12 items and produces 2 summary scores: the physical component summary and the mental component summary scores. The SF-12 summary scores are highly correlated with the summary scores obtained from the full SF-36. The physical component summary and the mental component summary are norm-based T scores with a mean of 50 (SD, 10) in the general population. Higher scores correlate with better health-related quality of life. The minimal clinically important difference is estimated between 3 to 5 points for each subscale. 20, 21 Physical examination We performed a physical examination at initial and subsequent evaluations including quantitative grip strength (Jamar Dynamometer, Lafayette Instrument Company, Lafayette, IN), pinch strength (B&L Engineering, Santa Ana, CA), the presence or absence of Froment's sign, and strength assessment of the first dorsal interosseous and flexor digitorum profundus to small finger (as graded by British Medical Council). Grip and pinch strength measurements were made on single maximal effort measures with the dynamometer in position 2. Grip and pinch strength were compared with the uninvolved contralateral side with less than 80% strength considered a significant difference representing moderate, Dellon 2, disease.
We used static 2-point discrimination of the small finger to assess for sensory changes in comparison with the contralateral hand as well as median nerve innervated digits and considered a discrimination greater than 5 mm to be abnormal. In addition, we performed provocative ulnar nerve testing, including a Tinel sign at the elbow and an elbow flexion compression test. 6 We assessed for a Tinel sign by applying 4 to 6 taps to the patient's ulnar nerve just proximal to the cubital tunnel. We recorded the presence or absence of the patients experiencing a tingling sensation in the small finger. We also assessed combined flexion with pressure provocation test by placing the patient's elbow in maximum flexion and, while in this position, placing pressure on the ulnar nerve just proximal to the cubital tunnel. We applied the test for a maximum of 60 seconds, seeking reproduction of paresthesias in the ring or small finger. These data were used to determine severity, and patients were classified according to Dellon. Finally, we evaluated all patients for stability of the ulnar nerve at the cubital tunnel and classified nerves as stable or unstable. Nerves were considered unstable if they were perchable, perching, or dislocating at the time of initial presentation. NIGHT SPLINTING IN CUBITAL TUNNEL SYNDROME Nerve studies Electromyography (EMG) and nerve conduction studies were performed on 20 of the 25 extremities and were positive in 17. The 17 with positive studies had slowed ulnar nerve conduction velocity across the elbow (judged against laboratory normal value provided on each study), but all had normal EMG findings. Four patients (5 elbows) declined electrophysiological studies but were included in the final analysis based on characteristic history and physical examination indicating cubital tunnel syndrome. 1 All 5 of these elbows had Dellon 1 cubital tunnel syndrome without intrinsic weakness.
Statistical methods
An initial power analysis was conducted in order to determine the sample size needed for this study. The minimum detectable change of the DASH at 95% confidence is assumed to be 13 DASH points (SD, 15 from the normative general population data). Therefore, to test the null hypothesis of equality of treatment group to pretreatment group at P ϭ .05 with 80% power and assuming a uniform dropout rate of 10%, we determined that 25 extremities would be sufficient.
The results of the QuickDASH and SF-12 questionnaires and clinical variables were recorded at initial presentation and at each follow-up interval. A 2-sample paired t-test was used to evaluate the mean changes in QuickDASH score and SF-12 between the pre-and posttreatment visits. A Bonferroni correction was applied owing to the multiple comparisons (P Ͻ .0125, significant). Missing data were excluded during analysis.
RESULTS
Twenty-one of 24 extremities were treated successfully without surgery, an 88% success rate. This included 18 of 20 Dellon 1 and 3 of 4 Dellon 2 cases. We analyzed the primary patient-rated outcome measures, the Quick-DASH and SF-12 physical component summary and mental component summary, for the 21 successfully treated extremities (Table 1 ). All were significantly improved by the 3-month follow-up and through the final follow-up; none of those successfully treated by splinting and activity modification had worsening of the Dellon stage.
Patients were compliant with the orthosis at least 80% of the time for 15 of the 18 patients (24 extremities) available for follow-up at 6 weeks and 14 of the 18 patients at 3 months (Fig. 2) . The patients unable to adhere to the splinting protocol at least 50% of the time cited pain at the medial and/or lateral bony prominences of the elbow as the major reason for noncompliance. At the end of the 3-month trial, 4 patients continued inter-
Week Compliance (18 PaƟents)
100% (9) >80% (6) >50% (2) <50% (1) 0% (0) 3 Month Compliance (18 PaƟents) 100% (7) >80% (7) >50% (2) <50% (0) 0% (2) FIGURE 2: Night splinting compliance at 6 weeks and 3 months. mittent orthosis wear for cubital tunnel symptom flare episodes. All continued to modify daily activities to minimize ulnar nerve symptoms as long as these modifications did not limit their daily life. Those modifications deemed to be necessary for daily life (ie, overhead lifting activities and exercises) were resumed once nerve symptoms improved. Activity resumption did not cause symptom recurrence. Eleven of the 21 successfully treated extremities were available for a final physical examination by a surgeon not involved in the initial care of the patient at an average of 22 months from initial presentation. Average grip strength of the affected extremity increased from 32 kg (Ϯ 15) to 35 kg (Ϯ 15) (P ϭ .04). Key pinch strength of the affected extremity remained unchanged at 10 kg (Ϯ 2). The 2 extremities initially presenting with a Froment sign resolved at follow-up. There were 2 extremities with decreased strength of the first dorsal interosseous muscle before treatment, with a British Medical Council strength of 4, and both were normal at follow-up. Similarly, 3 extremities had 4/5 flexor digitorum profundus strength of the small finger before treatment and improved to 5/5 at final follow-up. Three extremities had abnormal 1-point discrimination (8 mm for each) of the small finger before treatment. These normalized at follow-up. Nine of 11 extremities had resolution of provocative ulnar nerve tests at final follow-up.
Sixteen of the 24 extremities had a stable ulnar nerve, and 15 of these had symptom resolution with splinting. There were 8 unstable ulnar nerves, and 6 had symptom resolution with splinting.
Treatment failures
Three patients had persistent symptoms and underwent surgery. One patient wore her splint less than 50% of the time owing to medial elbow bony prominence pain, and another wore her splint more than 80% of the time. The third patient had bilateral symptoms and wore his splint 100% of the time for the first 3 months. He had resolution of symptoms on his nondominant left side; but because of continued symptoms on his dominant side, he underwent surgery 1 year after initiating nonoperative treatment.
DISCUSSION
Eighty-eight percent of patients in this cohort with mild or moderate symptoms were treated successfully with rigid night splinting and activity modifications. Both QuickDASH and SF-12 scores showed statistically and clinically relevant improvement within 3 months of treatment. The improvements noted at 3 months were maintained at final average follow-up of 2 years.
The role of conservative treatment for patients with mild to moderate cubital tunnel symptoms is unclear. Previous authors have found that those presenting with mild, acute symptoms may resolve spontaneously or can be treated with information and activity modifications to relieve ulnar nerve irritation. [23] [24] [25] Eisen and Danon 26 followed 22 patients with mild symptoms for a mean of 22 months and noted 90% spontaneous recovery. However, other authors have concluded that those patients with moderate symptoms will fail conservative management. 1 Night splinting has long been considered a staple of conservative treatment for cubital tunnel syndrome, but 2 issues bear consideration: the ability of the splint to maintain the elbow at the ideal position of 40°to 50°of flexion 11 and patient compliance with night splinting. An evaluation of various elbow orthoses by Apfel and Sigafoos 27 demonstrated that only the Hely & Weber cubital tunnel splint, an adjustable rigid orthosis with stockinette arm bands, was rigid enough to prevent flexion beyond 53°and also prevent full extension; other splints failed to maintain a position of midflexion. Our experience with the Hely & Weber splint has been similar, and we believe it effectively immobilizes the elbow at 45°of flexion.
Patient compliance is vital to the effectiveness of night splinting for cubital tunnel syndrome. Previous studies have failed to quantitatively evaluate patient compliance with splinting protocols. In our current cohort, the relatively short duration of treatment (3 months) seems to be well tolerated by a majority of our patients. Over 80% of our cohort wore their rigid night splints greater than 80% of the time with less than 5% to 10% of patients wearing it less than 50% of the time. Factors that seem to influence patient compliance include splinting with a comfortable, nonbulky splint for a relatively short treatment period of 3 months.
There is no consensus on the treatment length for rigid night splinting. Seror 13 studied 22 patients treated with night splinting for 6 months and showed success similar to ours. Dellon et al 12 prospectively evaluated 121 patients given conservative treatment for 3 to 6 months. Treatments ranged from nighttime towel wrapping to thermoplastic splinting, along with daytime activity modifications. After 6 months of treatment, their success rate was 42% for those with mild symptoms and 34% for those with moderate symptoms. In addition, the need for surgical intervention was 21% within 6 years for those with mild symptoms and 33% within 3 years for those with moderate symptoms. 12 This is in comparison with our surgical intervention rate of 13% at 2 years with a more standardized, but shorter treatment protocol.
One previous study suggested that night splinting was not more effective than other conservative treatment modalities. Svernlöv et al 14 prospectively evaluated 57 patients with nerve gliding exercises, splinting, or information aimed at protecting the ulnar nerve and reported that there was no treatment benefit of night splinting compared with the other groups because 51 of 57 patients were improved at 6 months. Their population, despite including Dellon 1 and 2 patients, was different from ours because 85% of our patients had positive nerve studies and 76% of their patients had normal nerve studies. In addition, patient compliance with splinting was not recorded, and the orthosis they used was meant to prevent elbow flexion beyond 45°, but it was unclear how successful it was at preventing flexion or if it was able to prevent full extension. This study provides useful information and supports the concept that many of these patients will improve with conservative measures.
The primary weakness of our study was the lack of a control group from which we could assess the natural history of untreated, mild cubital tunnel symptoms. A randomized trial with a splinting group and an observational group and/or an activity modification group would be the ideal. In addition, our study population was predominately Dellon 1 patients and 4 Dellon 2 patients. Although 3 of the 4 Dellon type 2 patients improved during the course of this study, they represented a small cohort of moderately affected patients.
Based on the findings of this study, we treat patients with mild to moderate cubital tunnel symptoms with instructions on activity modification and rigid night splinting for 3 months before surgical consideration.
